Abstract
The 50, 10, and 1% human infective doses of poliovirus type 1 vaccine administered orally to 32 infants were estimated to be 72, 39, and 20 tissue culture infective doses, respectively.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- KOPROWSKI H. Immunization against poliomyelitis with living attenuated virus. Am J Trop Med Hyg. 1956 May;5(3):440–452. doi: 10.4269/ajtmh.1956.5.440. [DOI] [PubMed] [Google Scholar]
- KOPROWSKI H. Living attenuated poliomyelitis virus as an immunizing agent of man. S Afr Med J. 1955 Oct 29;29(49):1134–1142. [PubMed] [Google Scholar]
- KOPROWSKI H., NORTON T. W., JERVIS G. A., NELSON T. L., CHADWICK D. L., NELSEN D. J., MEYER K. F. Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus. J Am Med Assoc. 1956 Mar 17;160(11):954–966. doi: 10.1001/jama.1956.02960460032008. [DOI] [PubMed] [Google Scholar]
- Katz M., Plotkin S. A. Minimal infective dose of attenuated poliovirus for man. Am J Public Health Nations Health. 1967 Oct;57(10):1837–1840. doi: 10.2105/ajph.57.10.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minor T. E., Helstrom P. B., Nelson D. B., D'Alessio D. J. Counterimmunoelectrophoresis test for immunoglobulin M antibodies to group B coxsackievirus. J Clin Microbiol. 1979 Apr;9(4):503–506. doi: 10.1128/jcm.9.4.503-506.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PLOTKIN S. A., KOPROWSKI H., STOKES J., Jr Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics. 1959 Jun;23(6):1041–1062. [PubMed] [Google Scholar]
- SABIN A. B. Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc. 1956 Dec 29;162(18):1589–1596. doi: 10.1001/jama.1956.02970350005002. [DOI] [PubMed] [Google Scholar]